中国医药
中國醫藥
중국의약
CHINA MEDICINE
2011年
8期
944-946
,共3页
李红燕%玛依努尔%孟学刚%白婷%党辉%王成凤
李紅燕%瑪依努爾%孟學剛%白婷%黨輝%王成鳳
리홍연%마의노이%맹학강%백정%당휘%왕성봉
高血压%脑梗死%脉搏波传导速度%晚期糖基化终产物
高血壓%腦梗死%脈搏波傳導速度%晚期糖基化終產物
고혈압%뇌경사%맥박파전도속도%만기당기화종산물
Hypertension%Cerebral infarction%Pulse wave velocity%Advanced glycation end products
目的 探讨脉搏波传导速度(PWV)及血清晚期糖基化终产物(AGEs)在高血压病并发脑梗死过程中的作用.方法 选择2009年1月至2010年12月我院门诊未服用降压药物或停药2周以上的高血压病患者150例(A组)、高血压病合并脑梗死患者150例(B组),健康人群50例作为正常对照组(C组).应用自动PWV分析仪测定颈-股动脉脉搏波传导速度(CFPWV)和颈-桡动脉脉搏波传导速度(CRPWV),采用酶联免疫吸附试验测定血清中AGEs浓度.结果 与A组的CFPWV[(12.76±1.25)m/s]、CRPWV[(10.79±0.95)m/s]及AGEs[(187.42±35.72)mg/L]相比,B组的CFPWV[(15.73±2.17)m/s]、CRPWV[(13.87±1.86)m/s]及AGEs[(286.53±43.29)mg/L]均明显增高;随着CFPWV、CRPWV及AGEs增高,高血压并发脑梗死危险性明显增加(P=0.015,P=0.008,P=0.027);二分类Logistic回归分析以脑梗死为因变量,以年龄、SBP、DBP、CFPWV、CRPWV和AGEs为自变量,发现CFPWV、CRPWV及AGEs为高血压并发脑梗死的独立危险因素,OR、95%CI及P值分别为3.95、2.37~8.19、0.019;4.28、1.53~7.62、0.032;3.87、2.57~8.39、0.019.结论 PWV增快及血清中AGEs浓度增高是高血压病患者并发脑梗死的独立危险因素.
目的 探討脈搏波傳導速度(PWV)及血清晚期糖基化終產物(AGEs)在高血壓病併髮腦梗死過程中的作用.方法 選擇2009年1月至2010年12月我院門診未服用降壓藥物或停藥2週以上的高血壓病患者150例(A組)、高血壓病閤併腦梗死患者150例(B組),健康人群50例作為正常對照組(C組).應用自動PWV分析儀測定頸-股動脈脈搏波傳導速度(CFPWV)和頸-橈動脈脈搏波傳導速度(CRPWV),採用酶聯免疫吸附試驗測定血清中AGEs濃度.結果 與A組的CFPWV[(12.76±1.25)m/s]、CRPWV[(10.79±0.95)m/s]及AGEs[(187.42±35.72)mg/L]相比,B組的CFPWV[(15.73±2.17)m/s]、CRPWV[(13.87±1.86)m/s]及AGEs[(286.53±43.29)mg/L]均明顯增高;隨著CFPWV、CRPWV及AGEs增高,高血壓併髮腦梗死危險性明顯增加(P=0.015,P=0.008,P=0.027);二分類Logistic迴歸分析以腦梗死為因變量,以年齡、SBP、DBP、CFPWV、CRPWV和AGEs為自變量,髮現CFPWV、CRPWV及AGEs為高血壓併髮腦梗死的獨立危險因素,OR、95%CI及P值分彆為3.95、2.37~8.19、0.019;4.28、1.53~7.62、0.032;3.87、2.57~8.39、0.019.結論 PWV增快及血清中AGEs濃度增高是高血壓病患者併髮腦梗死的獨立危險因素.
목적 탐토맥박파전도속도(PWV)급혈청만기당기화종산물(AGEs)재고혈압병병발뇌경사과정중적작용.방법 선택2009년1월지2010년12월아원문진미복용강압약물혹정약2주이상적고혈압병환자150례(A조)、고혈압병합병뇌경사환자150례(B조),건강인군50례작위정상대조조(C조).응용자동PWV분석의측정경-고동맥맥박파전도속도(CFPWV)화경-뇨동맥맥박파전도속도(CRPWV),채용매련면역흡부시험측정혈청중AGEs농도.결과 여A조적CFPWV[(12.76±1.25)m/s]、CRPWV[(10.79±0.95)m/s]급AGEs[(187.42±35.72)mg/L]상비,B조적CFPWV[(15.73±2.17)m/s]、CRPWV[(13.87±1.86)m/s]급AGEs[(286.53±43.29)mg/L]균명현증고;수착CFPWV、CRPWV급AGEs증고,고혈압병발뇌경사위험성명현증가(P=0.015,P=0.008,P=0.027);이분류Logistic회귀분석이뇌경사위인변량,이년령、SBP、DBP、CFPWV、CRPWV화AGEs위자변량,발현CFPWV、CRPWV급AGEs위고혈압병발뇌경사적독립위험인소,OR、95%CI급P치분별위3.95、2.37~8.19、0.019;4.28、1.53~7.62、0.032;3.87、2.57~8.39、0.019.결론 PWV증쾌급혈청중AGEs농도증고시고혈압병환자병발뇌경사적독립위험인소.
Objective To investigate the effects of pulse wave velocity(PWV) and advanced glycation end products(AGEs) on hypertension complicated with cerebral infarction. Methods Overall 350 subjects were enrolled in this study: 150 patients with primary hypertension without cerebral infarction, 150 patients with primary hypertension complicated with cerebral infarction and 50 aged-matched normotension control (NT) subjects. All of them were detected pulse wave velocity(CFPWV, CRPWV) and the serum concentration of AGEs. Results Compared with primary hypertension without cerebral infarction patients, the CFPWV, CRPWV and AGEs of the patients with primary hypertension complicated with cerebral infarction were significantly higher [CFPWV(12.76±1.25)m/s vs (15.73 ±2.17)m/s], CRPWV(10.79 ±0.95)m/s vs(13.87 ±1.86)m/s and [AGEs(187.42±35.72)mg/L vs (286.53 ±43.29)mg/L]. Furthermore, with the increase of CFPWV, CRPWV and AGEs, the morbidity of primary hypertension complicated cerebral infarction were markedly increased(P=0.015, P = 0.008, P = 0. 027). Logistic analysis showed that CFPWV, CRPWV and AGEs were independently correlated with primary hypertension complicated cerebral infarction respectively. Conclusion The increasing of PWV and AGEs might be involved in the development of primary hypertension complicated with cerebral infarction.